Try our beta test site
378 studies found for:    vaginal cancer
Show Display Options
Rank Status Study
21 Active, not recruiting Image-Guided Gynecologic Brachytherapy
Conditions: Cervical Cancer;   Uterine Cancer;   Vaginal Cancer;   Carcinoma of the Vulva
Intervention: Procedure: Image-guided brachytherapy
22 Completed Effectiveness of an Individualized Symptom Education Program (ISEP)
Conditions: Uterine Cancer;   Cervical Cancer;   Vaginal Cancer;   Vulvar Cancer
Intervention: Behavioral: Individualized Symptom Education
23 Completed
Has Results
A Study of V503, a 9-valent Human Papillomavirus (9vHPV) Vaccine in Females 12-26 Years of Age Who Have Previously Received GARDASIL™ (V503-006)
Conditions: Cervical Cancers;   Vulvar Cancers;   Vaginal Cancers;   Genital Warts
Interventions: Biological: V503;   Biological: Placebo to V503
24 Completed Magnetic Resonance Imaging Guided Gynecologic Brachytherapy
Conditions: Cervix Neoplasms;   Uterine Neoplasms;   Vaginal Neoplasms;   Vulvar Neoplasms
Intervention: Procedure: Brachytherapy
25 Completed
Has Results
Immunogenicity to Human Papillomavirus Vaccine (Gardasil) Among IBD Patients on Immunosuppressive Therapy
Condition: Inflammatory Bowel Disease
Intervention: Biological: Gardasil vaccine
26 Completed Topotecan in Treating Patients With Gynecologic Cancer That Cannot Be Removed by Surgery
Conditions: Cervical Cancer;   Endometrial Cancer;   Fallopian Tube Cancer;   Ovarian Cancer;   Sarcoma;   Vaginal Cancer;   Vulvar Cancer
Interventions: Drug: topotecan hydrochloride;   Other: pharmacological study
27 Completed Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic Cancer
Conditions: Cervical Cancer;   Endometrial Cancer;   Fallopian Tube Cancer;   Ovarian Cancer;   Peritoneal Cavity Cancer;   Sarcoma;   Vaginal Cancer;   Vulvar Cancer
Intervention: Drug: docetaxel
28 Unknown  Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer
Conditions: Breast Cancer;   Cervical Cancer;   Endometrial Cancer;   Fallopian Tube Cancer;   Ovarian Cancer;   Primary Peritoneal Cavity Cancer;   Prostate Cancer;   Sarcoma;   Vaginal Cancer;   Vulvar Cancer
Interventions: Genetic: gene expression analysis;   Genetic: gene rearrangement analysis;   Genetic: polymorphism analysis;   Other: laboratory biomarker analysis;   Radiation: radiation therapy
29 Recruiting Examining the Role of Transrectal High Intensity Focused Ultrasound (HIFU) in Rectal Pelvic Cancer
Conditions: Rectal Cancer;   Ovarian Cancer;   Endometrial Cancer;   Vaginal Cancer;   Cervical Cancer
Intervention: Device: Sonablate 500 (High Intensity Focused Ultrasound (HIFU))
30 Unknown  Hyperbaric Oxygen Therapy in Treating Long-Term Gastrointestinal Adverse Effects Caused by Radiation Therapy in Patients With Pelvic Cancer
Conditions: Bladder Cancer;   Cervical Cancer;   Colorectal Cancer;   Endometrial Cancer;   Gastrointestinal Complications;   Long-term Effects Secondary to Cancer Therapy in Adults;   Ovarian Cancer;   Prostate Cancer;   Radiation Toxicity;   Sarcoma;   Testicular Germ Cell Tumor;   Vaginal Cancer
Interventions: Other: questionnaire administration;   Procedure: gastrointestinal complications management/prevention;   Procedure: quality-of-life assessment
31 Recruiting E7 TCR T Cells With or Without PD-1 Blockade for Human Papillomavirus-Associated Cancers
Conditions: Cervical Cancer;   Vaginal Cancer;   Anal Cancer;   Penile Cancer;   Oropharyngeal Cancer
Interventions: Biological: E7 TCR Transduced PBL cells;   Drug: pembrolizumab;   Drug: aldesleukin;   Drug: fludarabine;   Drug: cyclophosphamide
32 Unknown  Nutritional Supplements in Improving Quality of Life During First-Line Chemotherapy in Patients With Metastatic Gynecological Cancer
Conditions: Cervical Cancer;   Endometrial Cancer;   Fallopian Tube Cancer;   Ovarian Cancer;   Sarcoma;   Vaginal Cancer;   Vulvar Cancer
Interventions: Dietary Supplement: therapeutic nutritional supplementation;   Procedure: standard follow-up care
33 Completed T Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated Cancers
Conditions: Vaginal Cancer;   Cervical Cancer;   Anal Cancer;   Penile Cancer;   Oropharyngeal Cancer
Interventions: Drug: Fludarabine;   Drug: Cyclophosphamide;   Biological: E6 TCR;   Drug: Aldesleukin
34 Completed
Has Results
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Human Papillomavirus-Associated Cancers
Conditions: Cervical Cancer;   Oropharyngeal Cancer;   Vaginal Cancer;   Anal Cancer;   Penile Cancer
Interventions: Drug: Fludarabine;   Drug: Cyclophosphamide;   Biological: Young TIL;   Drug: Aldesleukin
35 Completed Phase I Study of Intravenous Triapine (IND # 68338) in Combination With Pelvic Radiation Therapy With or Without Weekly Intravenous Cisplatin Chemotherapy for Locally Advanced Cervical, Vaginal, or Pelvic Gynecologic Malignancies
Conditions: Recurrent Cervical Cancer;   Recurrent Ovarian Epithelial Cancer;   Recurrent Vaginal Cancer;   Recurrent Vulvar Cancer;   Stage III Vaginal Cancer;   Stage IIIA Cervical Cancer;   Stage IIIA Ovarian Epithelial Cancer;   Stage IIIA Vulvar Cancer;   Stage IIIB Cervical Cancer;   Stage IIIB Ovarian Epithelial Cancer;   Stage IIIB Vulvar Cancer;   Stage IIIC Ovarian Epithelial Cancer;   Stage IIIC Vulvar Cancer;   Stage IV Ovarian Epithelial Cancer;   Stage IVA Cervical Cancer;   Stage IVA Vaginal Cancer;   Stage IVB Cervical Cancer;   Stage IVB Vaginal Cancer
Interventions: Drug: triapine;   Other: laboratory biomarker analysis;   Radiation: external beam radiation therapy;   Radiation: brachytherapy;   Drug: cisplatin;   Other: pharmacological study
36 Active, not recruiting Long-term Follow-up of Broad Spectrum Human Papillomavirus (HPV) Vaccine Study in Women (V503-021)
Conditions: Cervical Cancer;   Vulvar Cancer;   Vaginal Cancer;   Genital Warts;   Human Papillomavirus Infection
Interventions: Biological: V503;   Biological: GARDASIL
37 Recruiting Image-Guided Gynecologic Brachytherapy
Conditions: Cervical Cancer;   Uterine Cancer;   Vaginal Cancer;   Vulvar Cancer;   Bladder Cancer
Intervention: Device: Image-Guided Brachytherapy
38 Completed A Study to Evaluate Tolerability and Immunogenicity of V504 Administered Concomitantly With GARDASIL (V504-001)(COMPLETED)
Conditions: Cervical Cancer;   Vulvar Cancer;   Vaginal Cancer;   Genital Warts;   Human Papillomavirus Infection
Interventions: Biological: V504;   Biological: Comparator: Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine;   Biological: Comparator: Placebo (unspecified)
39 Completed
Has Results
Broad Spectrum HPV (Human Papillomavirus) Vaccine Study in 16-to 26-Year-Old Women (V503-001)
Conditions: Cervical Cancer;   Vulvar Cancer;   Vaginal Cancer;   Genital Warts;   Human Papillomavirus Infection
Interventions: Biological: Comparator: GARDASIL;   Biological: Experimental: V503
40 Completed Broad Spectrum HPV (Human Papillomavirus) Vaccine in 16 to 26 Year Old Women (V505-001)
Conditions: Cervical Cancer;   Vulvar Cancer;   Vaginal Cancer;   Genital Warts;   Human Papillomavirus Infection
Interventions: Biological: Comparator: V505 formulation 1;   Drug: Comparator: V505 formulation 2;   Biological: Comparator: V505 formulation 3;   Biological: Comparator: Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant;   Biological: Comparator: Placebo (unspecified)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.